Utah has approved Legion Health's AI chatbot to renew psychiatric medications without doctor supervision—only the second state to delegate clinical authority to AI. The $19/month service covers 15 low-risk maintenance drugs like Prozac, Zoloft, and Wellbutrin for patients already considered stable. No controlled substances, antipsychotics, or lithium—basically excluding anyone with complex psychiatric needs.
This feels like automation theater. The pilot carefully excludes everything difficult about psychiatric care while claiming to address provider shortages. The restrictions are so narrow—no recent dose changes, no psychiatric hospitalizations, mandatory check-ins every 10 refills—that it's targeting patients who probably don't need much clinical oversight anyway. Meanwhile, people struggling with ADHD, bipolar disorder, or severe depression remain stuck in the same broken system.
What's telling is the silence from other sources on this story. No psychiatric organizations defending the move, no patient advocacy groups celebrating expanded access. That suggests even Legion Health's carefully constructed pilot isn't generating much enthusiasm from the people it's supposed to help. The company is operating a waitlist rather than serving patients, which makes you wonder about actual demand.
For developers building healthcare AI, this pilot reveals the regulatory reality: start with the lowest-risk use cases and prove safety incrementally. But don't mistake narrow approvals for validation that AI is ready to replace clinical judgment. Legion Health found the easiest possible entry point into prescription authority—and that's probably the only way this gets approved anywhere.